PC
Polar Capital Portfolio holdings
AUM
$13.5B
This Quarter Return
+13.59%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$11.5B
AUM Growth
+$11.5B
(+5.5%)
Cap. Flow
-$598M
Cap. Flow
% of AUM
-5.2%
Top 10 Holdings %
Top 10 Hldgs %
26.57%
Holding
326
New
47
Increased
82
Reduced
126
Closed
45
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$67.4M |
| 2 |
Zimmer Biomet
ZBH
|
$61.7M |
| 3 |
Stryker
SYK
|
$61.3M |
| 4 |
HCA Healthcare
HCA
|
$56.9M |
| 5 |
US Foods
USFD
|
$51M |
Top Sells
| 1 |
ServiceNow
NOW
|
$68.9M |
| 2 |
Expedia Group
EXPE
|
$67.5M |
| 3 |
Sarepta Therapeutics
SRPT
|
$60M |
| 4 |
Edwards Lifesciences
EW
|
$57.8M |
| 5 |
Danaher
DHR
|
$50.5M |
Sector Composition
| 1 | Technology | 30.27% |
| 2 | Financials | 22.37% |
| 3 | Healthcare | 17.75% |
| 4 | Communication Services | 10.21% |
| 5 | Consumer Discretionary | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XYZ
126
Block, Inc.
XYZ
$48.5B
| $29.3M | 0.25% |
468,123
-95,634
| -17% | -$5.98M |
|
127
Entegris
ENTG
$12.7B
| $28.5M | 0.25% |
568,874
-228,608
| -29% | -$11.5M |
|
128
Texas Pacific Land
TPL
$21.5B
| $27.6M | 0.24% |
35,280
-24,546
| -41% | -$19.2M |
|
129
Accenture
ACN
$162B
| $27.1M | 0.24% |
128,673
-47,899
| -27% | -$10.1M |
|
130
RLI Corp
RLI
$6.22B
| $26.2M | 0.23% |
291,500
| – | – |
|
131
ProAssurance
PRA
$1.22B
| $25.3M | 0.22% |
700,000
| – | – |
|
132
Alamos Gold
AGI
$12.8B
| $24.5M | 0.21% |
3,501,808
+562,900
| +19% | +$3.93M |
|
133
Carnival Corp
CCL
$43.2B
| $24.2M | 0.21% |
476,154
-288,930
| -38% | -$14.7M |
|
|
BLU
134
DELISTED
BELLUS Health Inc.
BLU
| $23.4M | 0.2% |
3,023,625
+909,952
| +43% | +$7.05M |
|
135
Addus HomeCare
ADUS
$2.12B
| $23M | 0.2% |
237,038
| – | – |
|
|
NSTG
136
DELISTED
NanoString Technologies, Inc.
NSTG
| $23M | 0.2% |
825,000
-25,000
| -3% | -$696K |
|
137
Amgen
AMGN
$155B
| $22.3M | 0.19% |
92,500
-7,500
| -8% | -$1.81M |
|
|
SGEN
138
DELISTED
Seagen Inc. Common Stock
SGEN
| $22.3M | 0.19% |
195,000
+145,000
| +290% | +$16.6M |
|
139
Vertex Pharmaceuticals
VRTX
$100B
| $21.9M | 0.19% |
100,000
-25,000
| -20% | -$5.47M |
|
140
First American
FAF
$6.72B
| $21.9M | 0.19% |
375,000
+60,000
| +19% | +$3.5M |
|
|
STML
141
DELISTED
Stemline Therapeutics, Inc.
STML
| $21.3M | 0.19% |
2,000,000
+375,000
| +23% | +$3.99M |
|
142
Pfizer
PFE
$141B
| $21M | 0.18% |
534,919
-457,570
| -46% | -$17.9M |
|
|
PVG
143
DELISTED
PRETIUM RESOURCES INC.
PVG
| $20.6M | 0.18% |
1,849,519
-171,343
| -8% | -$1.91M |
|
144
Power Integrations
POWI
$2.53B
| $20.4M | 0.18% |
+206,349
| New | +$20.4M |
|
145
Incyte
INCY
$16.5B
| $19.9M | 0.17% |
228,360
-315,637
| -58% | -$27.6M |
|
146
Haemonetics
HAE
$2.63B
| $19.5M | 0.17% |
+169,432
| New | +$19.5M |
|
147
Aflac
AFL
$57.2B
| $18.7M | 0.16% |
353,000
-35,000
| -9% | -$1.85M |
|
148
James River Group
JRVR
$258M
| $18.5M | 0.16% |
+450,000
| New | +$18.5M |
|
149
SSR Mining
SSRM
$3.92B
| $18.3M | 0.16% |
+949,765
| New | +$18.3M |
|
150
NovaGold Resources
NG
$2.78B
| $18.1M | 0.16% |
+2,024,130
| New | +$18.1M |
|